About this white paper
The pet microbiome has moved from research curiosity to the center of product strategy. Pet parents now expect the same gut-health science they buy for themselves — and brands that answer with evidence, not buzzwords, are winning the shelf.
This white paper distills a decade of prebiotic research into a practical playbook: the market signals worth acting on, the clinical evidence behind Bimuno® GOS, and the formulation and regulatory guardrails for bringing a credible gut-health product to market.
What you'll learn
The market case
Why gut health is the fastest-growing claim in pet supplements, and where the white space is.
The science
A guided tour of 100+ published studies behind Bimuno® GOS, including pet-specific trials.
Formulation guidance
Dosing, stability and processing notes for treats, toppers, kibble and supplements.
Regulatory landscape
What you can claim today in the US and EU, and how to substantiate it.
“Formulators who treat the microbiome as a platform — not a single SKU — will own the next decade of pet health.”
